Using molecular biomarkers for precise risk stratification can save young patients from enduring treatments they may not otherwise need.
Over the last decade, CML has become a curable chronic disease for most patients, and many therapeutic options are now available.
This fact sheet explains myelofibrosis, treatment options, and quality of life issues to help patients and their loved ones cope with a diagnosis.
These tips can help patients with multiple myeloma learn more about how to cope with the disease.
Patients with chronic lymphocytic leukemia can use these tips to help manage practical and emotional concerns.
Many people see their cancer care as a collaboration. This fact sheet provides tips for patients with multiple myeloma for improving communication with providers during office visits.
This fact sheet reviews a number of resources available to patients coping with multiple myeloma, from the health care team to in the community.
Vorinostat (Zolinza) and Carfilzomib (PR-171) have shown promise as new treatment options for multiple myeloma patients.
By Justin M. Watts, MD; Peter Maslak, MD; Martin S. Tallman, MD
A 47-year-old woman presented for evaluation of pancytopenia. She ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|